Crossmark

ToTem: a tool for variant calling pipeline optimization

Crossref DOI link: https://doi.org/10.1186/s12859-018-2227-x

Published Online: 2018-06-26

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tom, Nikola http://orcid.org/0000-0001-7440-0515
Tom, Ondrej

Malcikova, Jitka

Pavlova, Sarka

Kubesova, Blanka

Rausch, Tobias

Kolarik, Miroslav

Benes, Vladimir

Bystry, Vojtech

Pospisilova, Sarka
Funding

Funding for this research was provided by:

EATRIS-CZ (M2015064, CZ.02.1.01/0.0/0.0/16_013/0001818)

CEITEC2020 (LQ1601)

Horizon 2020 (No 692298)

AZV-MZ-CR (15-30015A and 15-31834A)

Medical Faculty of Masaryk University grant (MUNI/A/0968/2017)
License Information

Text and Data Mining valid from 2018-06-26
More Information

Article History

Received: 3 January 2018

Accepted: 31 May 2018

First Online: 26 June 2018

Ethics approval and consent to participate

: The whole study and written informed consent obtained from all patients analysed for variant discovery in the TP53 were approved by the Ethical Committee of University Hospital Brno in concordance with the Declaration of Helsinki.For GIAB data, ethics approval is not required as the human data were publicly available on the GIAB website.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.